eFFECTOR Therapeutics- Warrants (26/08/2026) Current Cash

eFFECTOR Therapeutics- Warrants (26/08/2026) (EFTRW) currently reports a current cash of $470K as of June 2026. That compares with $1.1M in the prior-year period — down 58.5% year over year. Use the charts on this page to explore eFFECTOR Therapeutics- Warrants (26/08/2026)'s current cash history and peer comparisons.

eFFECTOR Therapeutics- Warrants (26/08/2026)'s current cash decreased from $1.1M to $470K — a 58.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

eFFECTOR Therapeutics- Warrants (26/08/2026) reported $470K in current cash as of June 2026. That compares with $1.1M in the prior-year period — down 58.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $470K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for eFFECTOR Therapeutics- Warrants (26/08/2026), and consider following EFTRW for alerts when major investors trade the stock.

eFFECTOR Therapeutics- Warrants (26/08/2026) is classified in the Healthcare sector. On current cash, it currently shows $470K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EFTRW with unrelated industries.